Lorenzo de la Rica, Research Programme Manager at Cancer Grand Challenges, provides his insights on the importance of the latest paper from the Cancer Grand Challenges eDyNAmiC team, tackling the extrachromosomal DNA…
13 April 2023
When it comes to cancer research, we regularly hear good news about the number of people benefiting from advances in treatment. But there is one bad news story about the condition that gets little attention. For three…
3 April 2023
Today we announce nine new Cancer Grand Challenges, for which Expressions of Interest are now open. These are the obstacles that continue to impede progress against cancer and that no one scientist, institution or…
8 March 2023
We are pleased to welcome five new members to the Cancer Grand Challenges Scientific Committee: Professor Michael Hall (University of Basel), Professor Sherene Loi (Peter MacCallum Cancer Center), Professor KJ Patel (…
7 March 2023
Lorenzo de la Rica (@LdelaRica) is Research Portfolio Manager at Cancer Grand Challenges
In 2022, we have seen our Cancer Grand Challenges (CGC) community grow, with four new teams receiving a total of $100m funding.…
16 December 2022
In 2017, the IMAXT team was awarded £20 million by Cancer Grand Challenges, funded by Cancer Research UK.
Through the Cancer Grand Challenges initiative, a global team of experts from fields as diverse as medicine,…
1 December 2022
We’re leading a global conversation to help shape our next round of funding, inviting the submission of ideas via our Online Ideas Portal from now until 28 November.
Here, Sheona Scales, Head of Research at Cancer…
7 November 2022
How a suite of advanced machine learning algorithms is finding new cancer-causing patterns of DNA damage
Cancer Grand Challenges researchers and collaborators have identified four new mutational signatures, including a…
14 October 2022
Advocacy plays a major role in Cancer Grand Challenges. The team taking on our Solid Tumours in Children challenge includes six advocates, representing the voice of children and families affected by solid cancers and…
21 September 2022